Cord Blood Banking Services Market: USD 49.85 Bn Opportunity to 2031 Led by Stem Cell Advancements, Says Mordor Intelligence

The global cord blood banking services market is projected to grow from USD 33.85 billion in 2025 to USD 49.85 billion by 2031, with a CAGR of 6.84%. Growth is driven by increasing awareness of stem cell therapies, advancements in regenerative medicine, and expanding clinical applications in treating hematological and genetic disorders. North America leads with 39.54% market share, while Asia-Pacific emerges as a high-growth region.

02/27/2026, 9:48 AM • GlobeNewswire

Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

Carterra Inc. announced the launch of the Carterra Vega, an industry-first 48-channel High-Throughput Surface Plasmon Resonance (HT-SPR) platform that delivers 12-fold higher throughput than competing systems. The platform enables primary screening of large molecular libraries with high-resolution binding data, capable of screening over 20,000 small molecule interactions per day. The first unit is scheduled for shipment in Q1 2026 to a top 10 pharmaceutical company.

02/09/2026, 11:00 AM • GlobeNewswire

Stock Market Today: Nasdaq 100, S&P 500, Dow Jones Futures Lag Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus (UPDATED)

U.S. stock futures declined on Tuesday ahead of December CPI data release. Major indices were trading lower with the S&P 500 down 0.12% and Nasdaq 100 down 0.19%. Key stocks in focus include Alphabet reaching $4 trillion market value, JPMorgan preparing to report Q4 earnings, Five9 expanding its Google Cloud partnership, and Revvity rising 4.92% after positive earnings guidance. Markets are pricing in a 95% likelihood of the Federal Reserve maintaining current interest rates in January.

01/13/2026, 8:29 AM • Benzinga

Stock Market Today: S&P 500, Dow Jones Futures Slip Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus

U.S. stock futures declined on Tuesday ahead of December CPI data release. Major indices were trading lower with the S&P 500 down 0.12% and Nasdaq 100 down 0.19%. Key stocks in focus include Alphabet (up on reaching $4 trillion market value), JPMorgan (ahead of earnings), Five9 (expanding Google Cloud partnership), Revvity (up 4.92% on earnings expectations), and Xpeng (down despite European expansion plans). Markets expect stable inflation at 2.7% annually and a 95% probability of unchanged Fed rates in January.

01/13/2026, 5:28 AM • Benzinga

Tech Stocks Rally, Gold Tumbles On US-China Trade Progress: What's Moving Markets Monday?

Wall Street extended its record-setting streak with major indices hitting all-time highs after a breakthrough in US-China trade negotiations. Trade tensions eased with potential tariff threats averted and promising discussions between diplomatic representatives.

10/27/2025, 1:03 PM • Benzinga

Revvity Slashes Outlook As China Policy Deals Diagnostics Blow

Revvity reported Q2 earnings beating estimates but lowered fiscal year 2025 guidance due to challenging macroeconomic conditions and China's new hospital laboratory reimbursement policy, which is impacting its immunodiagnostics business.

07/28/2025, 11:51 AM • Benzinga

Revvity Q2 Revenue Up 4 Percent

Revvity reported Q2 2025 financial results with $720 million revenue, exceeding estimates, but experiencing margin compression and slight earnings decline due to tariff pressures and challenging market conditions.

07/28/2025, 7:34 AM • The Motley Fool

CRISPR Gene Editing Market Surges USD 4.77 in 2025, `Vertex’s Casgevy, AI-Powered OpenCRISPR-1 and Trisomy 21 Breakthrough Fuels Growth

The global CRISPR gene editing market is projected to grow from USD 4.15 billion in 2024 to USD 16.47 billion by 2034, driven by technological advancements, increasing investments, and growing applications in biotechnology and healthcare.

07/08/2025, 10:00 AM • GlobeNewswire